S.Biomedics Co., Ltd. (KOSDAQ: 304360)
South Korea flag South Korea · Delayed Price · Currency is KRW
16,400
-830 (-4.82%)
Dec 20, 2024, 9:00 AM KST

S.Biomedics Ratios and Metrics

Millions KRW. Fiscal year is Jan - Dec.
Fiscal Year
CurrentFY 2023 FY 2022 FY 2021 FY 2020 FY 2019 2018 - 2017
Period Ending
Dec '24 Dec '23 Dec '22 Dec '21 Dec '20 Dec '19 2018 - 2017
Market Capitalization
192,631130,376----
Upgrade
Enterprise Value
196,217133,226----
Upgrade
Last Close Price
16400.0011500.00----
Upgrade
PS Ratio
14.369.95----
Upgrade
PB Ratio
18.4310.62----
Upgrade
P/TBV Ratio
38.0519.14----
Upgrade
EV/Sales Ratio
15.0710.16----
Upgrade
Debt / Equity Ratio
0.690.9813.331.781.170.35
Upgrade
Asset Turnover
0.370.470.570.490.260.22
Upgrade
Inventory Turnover
2.303.335.146.186.075.34
Upgrade
Quick Ratio
2.231.650.753.191.962.97
Upgrade
Current Ratio
2.752.030.953.442.123.14
Upgrade
Return on Equity (ROE)
-19.00%-97.08%-195.41%-121.47%-97.95%-64.37%
Upgrade
Return on Assets (ROA)
-10.37%-13.30%-11.13%-16.13%-26.13%-25.05%
Upgrade
Return on Capital (ROIC)
-13.33%-19.15%-18.41%-27.49%-38.11%-31.69%
Upgrade
Earnings Yield
-2.07%-5.77%----
Upgrade
FCF Yield
-2.66%-6.13%----
Upgrade
Buyback Yield / Dilution
-7.04%-6.97%-0.67%-0.42%-3.93%-406.19%
Upgrade
Total Shareholder Return
-7.04%-6.97%-0.67%-0.42%-3.93%-406.19%
Upgrade
Source: S&P Capital IQ. Standard template. Financial Sources.